It’s called vilazodone (Viibryd), and has been approved by the Food and Drug Administration for major depression, which is depression severe enough to interfere with a person’s ability to work, sleep, study, eat, or enjoy once pleasurable activities. The manufacturer says it’s less likely than some other antidepressants to cause sexual side effects or weight gain. But it’s unclear to us that it’s more effective or safer than any of the many antidepressants already on the market. And, like all new drugs, it by definition has a very short safety record. So we say proceed with caution until more is known.
For more about antidepressants, check out our free Best Buy Drugs report and also our advice on when talk therapy might be enough.
Similar Posts:
- People who thrive on little sleep are rare
- New FDA warnings for quinine, commonly used drug for leg cramps
- Supplemental estrogen: Some docs say one thing but do another
- More drug-containing supplements recalled
- FDA panel divided on pulling Avandia despite diabetes drug’s risks
